Allspring Global Investments Holdings, LLC Crispr Therapeutics Ag Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$51.17 - $68.18 $2.42 Million - $3.23 Million	-47,374 Reduced 60.02%	31,550 $1.7 Million
Q1 2024 Apr 18, 2024	BUY	$60.67 - $89.12 $2.54 Million - $3.73 Million	41,903 Added 113.19%	78,924 $5.38 Million
Q4 2023 Jan 25, 2024	SELL	$38.62 - $72.18 $9.67 Million - $18.1 Million	-250,373 Reduced 87.12%	37,021 $2.32 Million
Q3 2023 Oct 27, 2023	BUY	$45.39 - $59.0 $13 Million - $17 Million	287,394 New	287,394 $13 Million
Q2 2023 Jul 18, 2023	BUY	$43.47 - $67.77 $776,548 - $1.21 Million	17,864 Added 5.78%	326,698 $18.3 Million
Q1 2023 Apr 13, 2023	BUY	$41.0 - $56.12 $2.01 Million - $2.75 Million	48,972 Added 18.85%	308,834 $14 Million
Q4 2022 Jan 23, 2023	SELL	$39.19 - $65.67 $357,804 - $599,567	-9,130 Reduced 3.39%	259,862 $0
Q3 2022 Oct 26, 2022	SELL	$61.1 - $83.78 $292,730 - $401,389	-4,791 Reduced 1.75%	268,992 $17.6 Million
Q2 2022 Jul 25, 2022	SELL	$43.23 - $73.83 $12 Million - $20.5 Million	-277,781 Reduced 50.36%	273,783 $16.6 Million
Q1 2022 May 02, 2022	BUY	$53.19 - $79.24 $14.1 Million - $21 Million	264,969 Added 92.45%	551,564 $34.6 Million
Q4 2021 Jan 28, 2022	BUY	$70.09 - $111.29 $20.1 Million - $31.9 Million	286,595 New	286,595 $21.7 Million

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$367 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$347 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$139 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$137 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$137 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account